At what point the health Insurance will contribute to budget savings ? In recent days, the first elements of an answer have been given by the minister of Health Agnes Buzyn, and during the presentation of the draft finance law for 2018 (PLF).
As announced during the campaign of Emmanuel Macron, the national target of expenditure of health Insurance will be well set to +2.3% per year from 2018 to 2020, in order to save up to $ 15 billion during his five-year term. It seeks a return to the balance of the sickness Insurance. To reach this limit increases in spending, the savings required of the health Insurance will exceed gaily 4 billion, as against 4 billion euros last year, or 3.4 billion euros in 2015. The effort required will be so unprecedented.
The previous Draft of the law of financing of social security had encrypted the objective of spending 190,7 billion euros (+2.1 per cent) in 2017. He would reach 195 billion for the next year with this goal of +2.3%. Without savings, the total expenditure could be almost flirting with the bar 200 billion, according to the government, because of the aging of the population, and in parallel to the increase in the prevalence of chronic diseases such as diabetes.
Drug: Buzyn “evokes a considerable effort”
The drug, which today represents approximately 15% of the total expenditure of the social security, will be once again put to contribution. If we do not know yet the cost savings specific to the sector (the PLFSS 2018 will be presented tomorrow), Agnès Buzyn had referred to yesterday as a “tremendous effort” of more than 1 billion euros, with the increase in prescriptions of generic and lower prices of drugs mainly.
In June, the Insurance had it-even offer to save with its “own levers” of nearly 2 billion euros in 2018, by promoting the generic, of best requirements, combating fraud, among other things, but also by developing the shift to ambulatory care (fewer hospital admissions, more care in the city) and taken loads more “adequate” in the institution, to the tune of 470 million euros. The sum referred to does not include the outcome of the negotiations on the price of drugs in the framework of the committee economic health products (CEPS).
